MATTHEW OLSEN: Open Payments
NPI 1710698725 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 27 payments from 12 companies in 2025. Trend: 2023 $88 · 2024 $736 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $165 |
| Astellas Pharma US Inc | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Amgen Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: QULIPTA, Veozah, MAVYRET, Kerendia, CAPLYTA, INSPIRE, UBRELVY, Rybelsus.
Industry payments across AZ — which companies pay providers there.
